E 4.990918
li 5.289284
ĠLilly 3.4500608
Ġ& 3.0851808
ĠCo 0.40153062
's 5.187834
ĠThird 10.678877
- 1.8869791
Qu 1.219423
arter 0.10896231
ĠProf 6.5683293
its 0.5003734
ĠEx 6.14865
pected 3.813599
Ġto 0.37179878
ĠRise 2.1788476
, 3.4380448
Ġbut 2.2802289
ĠConcern 7.9323397
s 0.25289708
ĠOver 2.4779236
ĠProfit 6.7146373
ĠMarg 2.1594694
ins 1.111998
ĠRemain 3.1571276
ĠEli 11.938232
ĠLilly 0.011363776
Ġ& 0.6565691
ĠCo 0.02580426
Ġis 4.4457955
Ġexpected 0.9730601
Ġto 0.009533423
Ġreport 0.8013526
Ġhigher 4.392363
Ġthird 1.6567184
- 0.074420296
quarter 0.0029906242
Ġprofits 0.84340787
Ġand 2.7503707
Ġrevenue 2.991213
Ġwhen 6.675945
Ġthe 1.876129
Ġcompany 0.61281985
Ġannounces 4.149073
Ġearnings 2.0135386
Ġon 0.74618
ĠTuesday 2.3724873
, 0.8520881
Ġaccording 2.4612105
Ġto 0.0021213284
Ġanalysts 2.8743439
bytes:\xe2\x80 6.8747787
bytes:\x99 0.00197649
Ġestimates 1.2178178
Ġcompiled 3.6358788
Ġby 0.040991236
ĠBloomberg 0.77040756
. 0.18207982
ĠHowever 4.168944
, 0.012275962
Ġconcerns 3.8759816
Ġremain 2.2244263
Ġover 0.96006244
Ġnarrowing 11.973124
Ġprofit 0.8481588
Ġmargins 0.009294736
Ġfor 2.9754026
Ġthe 0.2925094
Ġpharmaceutical 3.5524979
Ġgiant 1.8668916
. 1.3549733
ĠLilly 4.236933
Ġis 2.3250768
Ġforecast 4.9360924
Ġto 0.13294502
Ġpost 2.0832164
Ġa 1.4987831
Ġ12 5.4479175
% 1.9890603
Ġincrease 1.2422004
Ġin 0.08263431
Ġearnings 2.2150843
Ġper 1.5876392
Ġshare 0.07346879
Ġto 2.3232398
Ġ$ 0.08882204
1 1.4812468
. 0.019387377
55 4.478601
Ġand 4.3869247
Ġa 0.91187274
Ġ7 3.4832869
. 1.6825888
3 2.3516438
% 0.019875368
Ġrise 2.5929441
Ġin 0.06901852
Ġrevenue 0.70063525
Ġto 0.47216502
Ġ$ 0.02818196
5 3.1076357
. 0.081667
43 5.5459967
Ġbillion 0.06912876
, 1.3948102
Ġcompared 3.55013
Ġwith 0.7264522
Ġthe 1.9588243
Ġsame 2.7221422
Ġquarter 1.7295765
Ġlast 0.22177897
Ġyear 0.0017101039
. 0.41666958
ĠOverall 6.5722537
, 0.3637803
ĠLilly 4.2449436
Ġhas 3.309373
Ġexceeded 8.549143
Ġanalysts 1.4684206
bytes:\xe2\x80 0.52070165
bytes:\x99 0.0015833542
Ġearnings 5.043237
Ġexpectations 1.0890222
Ġfor 0.83735615
Ġnine 6.2741075
Ġconsecutive 0.6227419
Ġquarters 0.029566944
. 1.1251314
ĠThe 1.9469173
Ġcompany 0.44832495
bytes:\xe2\x80 1.9536413
bytes:\x99 0.0013072822
s 0.00030141752
Ġshare 4.8184896
Ġprice 0.15246333
Ġis 1.6533725
Ġup 0.7426209
Ġ18 4.2934356
% 0.3409059
Ġso 2.7067952
Ġfar 0.0017462852
Ġthis 0.36578715
Ġyear 0.041049115
, 1.1168138
Ġoutper 5.481885
forming 0.0061066705
Ġthe 0.60744214
ĠS 0.33558652
& 0.00169237
P 0.0016046644
Ġ500 0.045940768
. 1.6558414
ĠThe 2.6925292
Ġexpected 7.7617006
Ġearnings 2.1800265
Ġgrowth 2.4365978
Ġis 1.4850458
Ġfueled 4.54349
Ġprimarily 6.2585597
Ġby 0.0063607343
Ġhigher 2.9017355
Ġsales 1.3054408
Ġof 0.7663344
Ġnew 4.6673727
Ġproducts 1.3733679
, 1.036053
Ġincluding 2.1348636
Ġthe 1.756662
Ġdiabetes 4.7763925
Ġdrugs 5.7402277
ĠJ 8.872184
ard 6.1188245
iance 1.2138323
Ġand 0.20610563
ĠTr 5.915766
ul 2.3568418
icity 1.7237886
Ġas 6.0381627
Ġwell 0.03441806
Ġas 0.005222024
Ġthe 1.189646
Ġcancer 3.658391
Ġtreatment 2.4391932
ĠVer 8.155575
zen 9.761246
io 6.043301
. 0.7338851
ĠTr 7.227769
ul 0.044266295
icity 0.027263252
Ġhas 3.0341616
Ġbeen 1.5057644
ĠLilly 7.4279838
's 0.92351633
Ġfastest 3.5347188
- 0.1800716
growing 0.412766
Ġproduct 0.5888275
Ġand 2.9731078
Ġsales 3.0226166
Ġrose 3.9408946
Ġover 5.762385
Ġ50 2.3078878
% 0.08751831
Ġlast 1.9806457
Ġquarter 0.87692964
Ġcompared 4.5297236
Ġto 2.2113905
Ġa 2.386535
Ġyear 0.4662928
Ġearlier 1.6656023
. 0.4478408
ĠHowever 4.077057
, 0.004243635
Ġrevenue 3.318948
Ġfrom 3.0267212
Ġsome 7.148912
Ġof 0.8092515
ĠLilly 1.8175808
bytes:\xe2\x80 1.0570157
bytes:\x99 0.0005172162
s 0.00019869342
Ġolder 1.8177657
Ġblockbuster 6.719191
Ġdrugs 0.6731688
Ġlike 3.2045808
ĠC 4.6221166
ial 2.4767191
is 0.0050062854
Ġand 0.60860306
ĠFort 8.590262
e 0.28602916
o 6.728889
Ġdeclined 3.064877
Ġdue 3.4324079
Ġto 0.023025619
Ġloss 7.9888997
Ġof 0.17487207
Ġpatent 3.4266555
Ġexclus 4.799101
ivity 0.020204542
Ġand 2.7687266
Ġcompetition 3.4043283
Ġfrom 1.1195788
Ġgeneric 1.6278968
Ġalternatives 3.569596
. 0.28439122
ĠWhile 4.427065
ĠLilly 2.311366
bytes:\xe2\x80 1.8416847
bytes:\x99 0.00055937853
s 0.00014718683
Ġtop 4.336847
- 1.5304458
line 0.2772542
Ġresults 3.7393157
Ġhave 1.9197004
Ġbeen 0.9568581
Ġsolid 2.565034
, 0.53331786
Ġprofit 4.8736625
Ġmargins 0.08236898
Ġhave 1.0944269
Ġbeen 0.78064185
Ġunder 4.1425095
Ġpressure 0.74983937
Ġdue 2.6848073
Ġto 0.020260984
Ġhigher 3.2501004
Ġcosts 1.1938218
. 2.0634265
ĠThe 1.8271309
Ġcompany 0.39189285
Ġhas 2.1024263
Ġinvested 6.115939
Ġheavily 1.1851265
Ġin 0.3085563
Ġresearch 2.246487
Ġand 0.16352057
Ġdevelopment 0.04883797
Ġto 1.5993761
Ġrest 8.863901
ock 1.9778954
Ġits 0.30799806
Ġproduct 2.29439
Ġpipeline 1.2750982
Ġas 4.2652636
Ġwell 0.6067046
Ġas 0.02922793
Ġin 3.1527681
Ġmarketing 3.041378
Ġand 1.2750702
Ġpromotions 5.965412
Ġto 1.4301915
Ġdrive 2.5005798
Ġsales 1.4600829
Ġof 1.9908096
Ġnew 2.123861
Ġdrugs 1.6345161
. 0.37881684
ĠLilly 3.0145092
bytes:\xe2\x80 1.7363263
bytes:\x99 0.0006728154
s 0.00014408647
Ġoperating 4.807127
Ġmargin 2.103874
Ġdeclined 3.5892675
Ġto 0.85451126
Ġ21 4.6901646
% 1.0484006
Ġlast 1.7628914
Ġquarter 0.20637624
Ġfrom 0.704505
Ġ24 2.4116077
% 0.17164876
Ġa 1.74778
Ġyear 0.00234242
Ġago 1.3968707
. 0.77277046
ĠLooking 6.946004
Ġahead 0.703998
, 0.13326067
ĠLilly 2.1681817
Ġaims 5.7762923
Ġto 0.03936528
Ġlaunch 5.547467
Ġ20 4.7829123
Ġnew 0.40352848
Ġproducts 1.2883099
Ġbetween 5.2751026
Ġ2018 4.6345587
Ġand 0.03352905
Ġ20 2.4090676
23 0.21813208
Ġto 4.1357965
Ġdrive 3.1904159
Ġfuture 4.713106
Ġgrowth 1.2876064
. 0.59674585
Ġ" 5.5448503
We 1.4765933
Ġremain 3.2480314
Ġconfident 1.8666377
Ġin 1.2197821
Ġour 0.514635
Ġlong 2.8777862
- 0.055926763
term 0.024067726
Ġoutlook 2.501346
, 1.8452686
bytes:\xe2\x80 1.3139676
bytes:\x9d 0.011923086
Ġsaid 1.1099936
ĠChief 3.7404141
ĠExecutive 0.2748685
ĠDavid 5.358332
ĠR 6.229298
icks 11.170416
Ġin 1.6247545
ĠLilly 7.218962
bytes:\xe2\x80 0.9606773
bytes:\x99 0.0003083335
s 0.00033737256
Ġsecond 3.7333581
- 0.18095021
quarter 0.0036586307
Ġearnings 0.38119817
Ġcall 0.8674768
. 0.40225065
ĠHowever 4.460725
, 0.005783604
Ġthe 1.76893
Ġcost 7.566123
Ġto 4.195661
Ġdevelop 2.7942371
Ġnew 1.4561985
Ġdrugs 0.5035163
Ġand 1.8333896
Ġgain 6.4589477
Ġregulatory 3.1049063
Ġapproval 0.26745778
Ġremains 2.1285446
Ġextremely 6.2239876
Ġhigh 0.36361036
Ġand 2.5231266
Ġuncertain 7.96899
. 0.4494542
ĠLilly 2.2784326
Ġfaces 4.081408
Ġnumerous 4.6154146
Ġnear 8.889693
- 0.052024882
term 0.005856986
Ġchallenges 0.82444966
, 1.4384161
Ġincluding 0.16679604
Ġpatent 4.056294
Ġexp 2.233838
ir 0.5237571
ations 0.0013774115
, 0.8705587
Ġpricing 5.494548
Ġpressures 2.073648
Ġin 3.9594014
Ġthe 0.86985457
ĠU 1.1393263
. 9.127325e-05
S 0.029443614
. 0.65041476
Ġmarket 2.377121
, 0.5611619
Ġand 0.71977764
Ġcompetitive 4.558708
Ġthreats 3.4882154
Ġfrom 0.45347267
Ġrival 5.2664967
Ġdrug 1.124948
makers 1.2437515
. 0.6511347
ĠWhile 3.8992357
ĠLilly 2.1491878
bytes:\xe2\x80 1.7605838
bytes:\x99 0.00039950278
s 0.0001815255
Ġinnovation 7.7135806
- 3.789532
driven 1.2958335
Ġgrowth 3.3148572
Ġstrategy 0.4231148
Ġhas 1.5462263
Ġstarted 7.9528537
Ġto 0.12745506
Ġpay 0.32081848
Ġoff 0.107531495
, 0.36847705
Ġinvestors 3.9940565
Ġwill 3.1095998
Ġbe 1.5038158
Ġclosely 3.319603
Ġmonitoring 1.7281468
Ġthe 0.8550847
Ġcompany 0.28462294
bytes:\xe2\x80 0.2072352
bytes:\x99 0.00041208262
s 0.0001010493
Ġmargins 5.5618496
Ġand 1.1474911
Ġpipeline 8.797526
Ġprogress 6.354762
Ġto 1.3773786
Ġensure 2.7397864
Ġsustainable 5.46276
Ġmomentum 6.5521293
Ġin 2.6645622
Ġthe 0.4652778
Ġcoming 1.7891244
Ġquarters 2.2547133
. 0.081584536
